Mycophenolate Mofetil (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Mycophenolate Mofetil drug offered from Mylan Institutional Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | mycophenolate mofetil |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-06-01 |
END MARKETING DATE: | 0000-00-00 |
Mycophenolate Mofetil HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycophenolate Mofetil from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2009-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51079-721_d4152532-a31b-4e89-9757-1f5f8e584c9b |
PRODUCT NDC: | 51079-721 |
APPLICATION NUMBER: | ANDA065520 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers: